PRECLINICAL EVALUATION OF AN IMPROVED FORMULATION OF HUMAN RECOMBINANT FVIII (KOGENATE-2) - TOXICOLOGY, PHARMACOLOGY, PHARMACOKINETICS, ANDNEOANTIGENICITY

Authors
KOWOLENKO M IRWIN R WROBLEWSKI V
Citation
M. Kowolenko et al., PRECLINICAL EVALUATION OF AN IMPROVED FORMULATION OF HUMAN RECOMBINANT FVIII (KOGENATE-2) - TOXICOLOGY, PHARMACOLOGY, PHARMACOKINETICS, ANDNEOANTIGENICITY, Thrombosis and haemostasis, 1997, pp. 2084-2084
Citations number
NO
Categorie Soggetti
Hematology,"Peripheal Vascular Diseas
Journal title
Thrombosis and haemostasis → ACNP
ISSN journal
03406245
Year of publication
1997
Supplement
S
Pages
2084 - 2084
Database
ISI
SICI code
0340-6245(1997):<2084:PEOAIF>2.0.ZU;2-X